dc.contributor.author |
Mayer, Frank |
de_DE |
dc.date.accessioned |
2014-02-18T08:56:05Z |
|
dc.date.available |
2014-02-18T08:56:05Z |
|
dc.date.issued |
2013 |
de_DE |
dc.identifier.issn |
0169-5002 |
de_DE |
dc.identifier.uri |
http://hdl.handle.net/10900/41829 |
|
dc.language.iso |
en |
en |
dc.publisher |
Elsevier Ireland Ltd |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1016/j.lungcan.2013.05.010 |
de_DE |
dc.rights |
info:eu-repo/semantics/closedAccess |
|
dc.subject.ddc |
610 |
de_DE |
dc.title |
Phase II study of pemetrexed and cisplatin plus cetuximab followed by pemetrexed and cetuximab maintenance therapy in patients with advanced nonsquamous non-small cell lung cancer |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20140116051827_00907 |
de_DE |
utue.publikation.seiten |
428-434 |
de_DE |
utue.personen.roh |
Schmid-Bindert, Gerald |
de_DE |
utue.personen.roh |
Gebbia, Vittorio |
de_DE |
utue.personen.roh |
Mayer, Frank |
de_DE |
utue.personen.roh |
Arriola, Edurne |
de_DE |
utue.personen.roh |
Marquez-Medina, Diego |
de_DE |
utue.personen.roh |
Syrigos, Kostas |
de_DE |
utue.personen.roh |
Biesma, Bonne |
de_DE |
utue.personen.roh |
Leschinger, Monika Iris |
de_DE |
utue.personen.roh |
Frimodt-Moller, Bente |
de_DE |
utue.personen.roh |
Ripoche, Veronique |
de_DE |
utue.personen.roh |
Myrand, Scott P. |
de_DE |
utue.personen.roh |
Nguyen, Tuan S. |
de_DE |
utue.personen.roh |
Hozak, Rebecca R. |
de_DE |
utue.personen.roh |
Zimmermann, Annamaria |
de_DE |
utue.personen.roh |
Visseren-Grul, Carla |
de_DE |
utue.personen.roh |
Schuette, Wolfgang |
de_DE |
dcterms.isPartOf.ZSTitelID |
Lung Cancer |
de_DE |
dcterms.isPartOf.ZS-Issue |
3 |
de_DE |
dcterms.isPartOf.ZS-Volume |
81 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |